PULSATILE DRUG DELIVERY SYSTEM: A REVIEW

1. M. Bajpai, D. C. P. Singh, A. Bhattacharya and A.
Singh. Design and In Vitro Evaluation of
Compression-coated Pulsatile Release Tablets of
Losartan Potassium, Ind. J. Pharm. Sci. 74(2): 101–
106 (2012).
2. A. Gupta. Review on recent advances in pulsatile
drug delivery systems: A vision for better future for
treatment of diseases, Int. Pharm. Sci. 2(2): 71-77
(2012).
3. K. P. Sadaphal, V. M. Thakare, B. R. Gandhi and B. W.
Tekade. Formulation and evaluation of pulsatile
drug delivery system for chronobiological disorder:
Asthma, Int. J. Drug Del. 3: 348-356 (2011).
4. B. Botti and C. Youan. Chronopharmaceutics:
gimmick or clinically relevant approach to drug
delivery, J. Cont. Rel. 98: 337-53 (2004).
5. B. R. Gandhi, A. S. Mundada and P. P. Gandhi.
Chronopharmaceutics: As a clinically relevant drug
delivery system, Drug Del. 18(1): 1-18 (2011).
6. S. S. Khadabadi, N. H. Chishti, F. M. Khan and A. A
Tadvee. Formulation and evaluation of press
coated tablet of ketoprofen – a chronotherapeutic
approach, Int. J. Pharm. and Pharmceut. Sci. 5(3):
733-740 (2013).
7. V. K. Kannan, C. Kannan, K. Jaganathan, K. S. G. Arul
Kumaran and R. S. Kumar. Formulation and in-vitro
evaluation of aceclofenac pulsatile tablets as a oral -
time controlled drug delivery system, Arch. Applied
Sci. Res. 5 (2):121-131 (2013).
8. D. K. Patel, M. R. Patel, K. R. Patel and N. M. Patel.
Formulation And In-Vitro Evaluation of Pulsatile
Release tablet of Lornoxicam, Amer. J. Pharm. Tech.
Res. 2(3): 842-855 (2012).
9. N. P. Chauhan, J. Deshpande, P. H. Upadhyay, S. R.
Shah and J. Trivedi. Time Controlled Pulsatile Drug
Delivery System-A Review, Amer. J. Pharm. Tech.
Res. 2(3): 46-59 (2012).
10. S. Patil, S. Pund, A. Joshi, C. J. Shishoo and A.
Shahiwala. Chronomodulated press-coated
pulsatile therapeutic system for aceclofenac:
optimization of factors influencing drug release and
lag time, ChronoPhys. and Ther. 1: 1–10 (2011).
11. M. Efentakis, S. Koligliati, and M. Vlachou. Design
and evaluation of a dry coated drug delivery system
with an impermeable cup, swellable top layer and
pulsatile release, Int. J. Pharm. 311:147–156
(2006).
12. F. Pozzi, P. Furlani, A. Gazzaniga, S. S. Davis and I. R.
Wilding. The Time Clock® system: A new oral dosage form
for fast and complete release of drug after a
predetermined lag time, J. Cont. Rel. 31: 99–108 (1994).
13. S. Sungthongjeen, S. Puttipipatkhachorn, O.
Paeratakul, A. Dashevsky and R. Bodmeier.
Development of pulsatile release tablets with
swelling and rupturable layers, J. Cont. Rel. 95:
147–159 (2004).
14. V. R. Sinha, J. R. Bhinge, R. Kumria and M. Kumar.
Development of pulsatile systems for targeted drug
delivery of celecoxib for prophylaxis of colorectal
cancer, Drug Deliv. 13: 221–225 (2006).
15. Y. E. Malah and S. Nazzal. Novel use of Eudragit®
NE 30D/Eudragit® L 30D-55 blends as functional
coating materials in time-delayed drug release
applications, Int. J. Pharm. 357: 219–227 (2008).
16. P. Roy and A. Shahiwala. Statistical optimization of
ranitidine HCl floating pulsatile delivery system for
chronotherapy of nocturnal acid breakthrough, Eur.
J. Pharm Sci. 37: 363–369 (2009).
17. S. Kamboj, G. D. Gupta and J. Oberoy. Matrix
Tablets: An Important Tool for Oral Controlled-
Release Dosage Forms, Pharma. Info. Net. 7 (6): 1-9
(2009).
18. S. Rathod. Colon Targeted Pulsatile Drug Delivery:
A Review, Pharma. info. net. 5(2): 1-11 (2007).
19. S. N. Ruma, P. P. Reddy, C. Divya, V. S. R.
Chandralekha, S. V. Shireesha and K. Anusha.
Formulation and characterization of pulsatile drug
delivery system of Dimethylxanthine, Nov. Sci, Int. J.
Pharm. Sci. 2(1-2): 26-35 (2013).
20. A. Singh, H. Dubey, I. Shukla and D. P. Singh.
Pulsatile Drug Delivery System: an Approach of
Medication according to Circadian Rhythm, J.
Applied Pharm. Sci. 02(03): 166-176 (2006).
21. V. N. L. Sirisha, M. Namrata, B. Sruthi, I. Harika, P. K.
Kumar, Y. K. K. Rao and K. Pranavi. Pulsatile Drug
Delivery System-A Review, Int. J. Pharm. Res. and
Allied Sci. 1(3): 13-23 (2012).
22. H. N. Singh, S. Saxena, S. Singh and A. K. Yadav.
Pulsatile Drug Delivery System: Drugs used in the
Pulsatile Formulations, Res. J. Pharma. Dosage
Forms and Tech. 5(3): 115-121 (2013).
23. S. Rathod. Colon Targeted Pulsatile Drug Delivery:
A Review, Pharma. Info. net. 5(2): 1-11 (2007).
24. G. R. Rao, P. Soumya, K. Revathi and B. S. Nayak. A
Review on pulsatile drug delivery system, Int. Res.
J. Pharm. 4(3): 31-44 (2013).
25. H. Dalvadia and J. K Patel. Chronpharmaceutics,
pulsatile drug delivery system as current trend,
Chronpharmaceutics, Asian J. Pharm. Sci. 5(5): 204-
230 (2010).
26. R. Kamat, A. R. Shabaraya, A. Mohammad and K.
Kamath. Formulation and Evaluation of pulsatile
Dolly et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
723 | P a g e
w w w . a r p b . i n f o
drug delivery system containing Indomethacin
using natural polymers, Int. Res. J. Pharm. 4(2):
111-114 (2013).
27. R. Sharma, A. Singh, S. Kumar and F. Jamil. Pulsatile
drug delivery system: A Review, Int. Res. J. Pharm.
3(7): 103-107 (2012).
28. R. K. Reddy, M. Veera Jyothsna, T. S. Mohamed and
C. M. S. Chetty. Review on: Pulsatile drug delivery
systems, J. Pharm. Sci. & Res. 1(4): 109-115 (2009).
29. S. Vinupama, S. Shwetha, S. Kamath, T. S. Keerthi
and S. Kumar. Pulsatile drug delivery system: A
Review, Int. Bulletin Drug Res. 1(1): 19-31 (2011).
30. Pulsystm in multiparticulate drug delivery, W. O.
Patent WO 016311 A1, 2005.
31. Diffucaps in multiparticulate drug delivery, Eurand
S.P.A. Corporation. U.S. Patent 72329344, 1972.
32. E. McNeill, A. Rashid, S. N. E. Howard. Dispensing
device, G.B. Patent GB2230442, 1993.
33. D. Patel, K. Aneja and S. H. Majumdar. Pulsatile drug
delivery system: a “user-friendly” dosage form, J.
Pharm. Res. and Health Care 2(2): 204-215 (2010).
34. S. Survase and N. Kumar. Pulsatile drug delivery:
Current scenario, Current Res. and Info. on Pharm.
Sci. 8(2): 27-33 (2007).
35. Z. Zhanga, X. Qi, X. Lia, J. Xinga, X. Zhua and W.
Zhenghong. A novel pulsatile drug delivery system
based on the physiochemical reaction between
acrylic copolymer and organic acid: In vitro and in
vivo evaluation, Int. J. Pharm. 462: 66– 73 (2014).
36. A. Maroni, M. D Del Curto, M. Cerea, L. Zema, A.
Foppoli and A. Gazzaniga. Polymeric coatings for a
multiple-unit pulsatile delivery system:
Preliminary study on free and applied films, Int. J.
Pharm. 440: 256– 263 (2013).
37. H. Huang, W. Zhenghong, Q. Xiaole, H. Zhang, Q.
Chen, J. Xing, H. Chen and Y. Ru. Compressioncoated
tablets of glipizide using
hydroxypropylcellulose for zero-order release: In
vitro and in vivo evaluation, Int. J. Pharm. 446:
211– 218 (2013).
38. S. Sokar, A. S. Hanafy, A. H. El-Kamel and S. S. E.
Gamal. Pulsatile core-in-cup valsartan tablet
formulations: In vitro Evaluation, Asian J. Pharm.
Sci. 8: 234-243 (2013).
39. S. Kumar, M. R. Kotaiah and M. P. Rao. Pulsatile
drug delivery system: A review, Int. J. Pharm Res.
and Bio-sci. 2(5):246-257 (2013).
40. S. Dandale, S. V. Deshmane and K. R. Biyani.
Formulation and evaluation of pressed coated
pulsatile tablet containing nifedipine, Int. J. Pharm.
4(7): 471-474 (2013).
41. M. Sandeep, V. S. Kishore, B. Sudheer, S. Ershad, K.
Adithya, and M. Srinivas. Preparation and
Evaluation of Chronopharmaceutical Drug Delivery
of Lansoprazole, Research and reviews, J. Pharm.
and Pharmaceut. sci. 2(4): 45-54 (2013).
42. V. Prasad, S. Vidya, M. Babu and P. V. Diwan.
Formulation of Pulsatile Delivery of Ramipril: A
Chrono-Pharmaceutical Approach for the
Treatment of Hypertension, Br. Biomed. Bull. 1(1):
005-017 (2013).
43. S. Jain, C. K. Sudhakar and S. Jain. Formulation and
evaluation of floating pulsatile drug delivery
system for chronotherapy of rheumatoid Arthritis,
Nov. Sci. Int. J. Pharm. Sci. 1(5): 212 -215 (2012).
44. S. Patel, M. K. Modasiya, V. M. Patel, A. K. Patel.
Design and development of floating pulsatile drug
delivery system using meloxicam, Int. J. Pharm. Res.
and bio-sci. 1(2): 215-235 (2012).
45. K. Garg, G. Gnanarajan and P. Kothiyal. Formulation
and Evaluation of Pulsatile Drug Delivery System of
Rosuvastatin Calcium Using Different Swelling
Polymers, The pharm. J. 1(7): 61-67 (2012).
46. S. Patil, A. M. Motagi, U. Kulkarni, R. C. Hariprasanna
and S. A. Patil. Development and evaluation of time
controlled pulsatile release Lisinopril tablets, J.
Pharm. Sci. and bioscient. Res. 2(1): 30-35 (2012).
47. M. Desai, R. R Jivani, L. D. Patel, N. P. Jivani, and B.
Sonagara. Development of time controlled
chronomodulated tablet with swelling and
rupturable layers: Optimization of factors
influencing lag-time and drug release, Int. J. Pharm.
Investig. 2(4): 208–212 (2012).
48. S. Masareddy, A. L. Gupta and D. Kurien.
Development and characterization of diltiazem
hydrochloride pulsatile drug delivery system for
chronomodulated therapy, Asian J. Pharm. Clin. Res.
4(2): 168-173 (2011).
49. S. Patil, S. Pund, A. Joshi, C. J. Shishoo and A.
Shahiwala. Chronomodulated press-coated
pulsatile therapeutic system for aceclofenac:
optimization of factors influencing drug release and
lag time, Chrono Phy. and Therapy 1: 1–10 (2011).
50. K. Salunkhe, R. J. Dias, K. K. Mali, N. S. Mahajan and
V. S. Ghorpade. Formulation and evaluation of
floating pulsatile drug delivery system of
Metoprolol tartrate, Der. Pharm. Let. 3(3): 147-160
(2011).
51. D. Yadav, S. Survase and N. Kumar. Dual coating of
swellable and rupturable polymers on Glipizide
loaded MCC pellets for pulsatile delivery:
Formulation design and in vitro evaluation, Int. J.
Pharm. 419: 121– 130 (2011).
Dolly et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
724 | P a g e
w w w . a r p b . i n f o
52. P. M. Dandagi, V. S Masthiholimath, A. P.
Gadad and B. K. Najwade. Development and
characterization of chronomodulated drug delivery
system of captopril, Int. J. Pharm. Investig. 1(4):
227–233 (2011).
53. P. Sadaphal, V. M. Thakare, B. R. Gandhi and B. W.
Tekade. Formulation and evaluation of pulsatile
drug delivery system for chronobiological disorder:
Asthma, Int. J. Drug Del. 3: 348-356 (2011).
54. S. Rujivipat and R. Bodmeier. Modified release from
hydroxypropyl methylcellulose compressioncoated
tablets, Int. J. Pharm. 402: 72–77 (2010).
55. S. Tajiri, T. Kanamaru, K. Makoto, T. Konno and H.
Nakagami. Dosage form design and in vitro/in vivo
evaluation of cevimeline extended-release tablet
formulations, Int. J. Pharm. 383: 99–105 (2010).
56. F. Liu, P. Moreno and A.W. Basit. A novel doublecoating
approach for improved pH-triggered
delivery to the ileo-colonic region of the
gastrointestinal tract, Eur. J. Pharm. and Biopharm.
74: 311–315 (2010).
57. Y. Nayak, G. V. Shavi, Y. Nayak, R. K. Averinen, S.
Mutalik, S. M. Reddy, P. D. Gupta and N. Udupa.
Chronotherapeutic drug delivery for early morning
surge in blood pressure: A programmable delivery
system, J. Cont. Rel. 136: 125–131 (2009).
58. H. Lin, Shyr-Yi Lin, Ying-Ku Lin, Hsiu-O Hoa, Yo-
Wen Lo and Ming-Thau Sheu. Release
characteristics and in vitro–in vivo correlation of
pulsatile pattern for a pulsatile drug delivery
system activated by membrane rupture via osmotic
pressure and swelling, Eur. J. Pharm. and Biopharm.
70: 289–301 (2008).
59. M. Amir, A. Ahuja, S. Baboota and J. Ali.
Chronomodulated Drug Delivery System of
Salbutamol Sulphate for the Treatment of
Nocturnal Asthma, Ind. J. Pharm. Sci. 70(3): 351–
356 (2008).
60. C. A. Schellekens, F. Stellaard, D. Mitrovic, F. E.
Stuurman, J. G. W. Kosterink and H. W. Frijlink.
Pulsatile drug delivery to ileo-colonic segments by
structured incorporation of disintegrants in pHresponsive
polymer coatings, J. Cont. Rel. 132: 91–
98 (2008).
61. S. Badve, P. Sher, A. Korde and A. P. Pawar.
Development of hollow/porous calcium pectinate
beads for floating-pulsatile drug delivery, Eur. J.
Pharm. and Biopharm. 65: 85–93 (2007).
62. M. Ghimire, F. J. McInnes, D. G. Watson, A. B. Mullen
and H. N. E. Stevens. In-vitro/in-vivo correlation of
pulsatile drug release from press-coated tablet
formulations: A pharmacoscintigraphic study in the
beagle dog, Eur. J. Pharm. and Biopharm. 67: 515–
523 (2007).
63. S. Sharma and A. Pawar. Low density
multiparticulate system for pulsatile release of
meloxicam, Int. J. Pharm. 313: 150–158 (2006).
64. A. Mullen, H. Stevens and S. Eccleston. Pulsatile
drug release, U.S. Patent US 0022676 A1, 2013.
65. A. Taillardat and R. F. Wagner. Pulsatile release of
valsartan, E.P. Patent EP 2285358 A1, 2011
66. M. Sorensen, L. Leopold and D. Yang. Pulsatile
dosing of gossypol for the treatment of disease,
W.O. Patent WO2010056932 A1, 2010.
67. R. Muthusamy and M. G. K.
Kulkarni. Pulsatile release composition of
therapeutic agent, W.O. Patent WO2010103367 A1,
2010.
68. A. S Gandhi, N. R. Palepu, P. S. Pilgaonkar and M. T.
Rustomjee. Valsartan formulation
for pulsatile delivery, W. O. Patent WO 2008064338
A2, 2008.
69. M. G. Dedhiya, A. Chhettry and Y. Yang. Modified
and pulsatile release pharmaceutical formulations
of escitalopram, E. P. Patent EP1962831 A2, 2008.
70. R. C. A. Schellekens and H. W. Frijlink. pHcontrolled
pulsatile delivery system, methods for
preparation and use thereof, W.O. Patent
WO2007013794 A1, 2007.
71. J. Hirsh, R. Rariy and M. Heffernan. Pulsatile release
compositions of milnacipran, U.S. Patent US
0003004A1, 2006.
72. P. J. Percel, K. S. Vishnupad, G. M. Venkatesh and Y.
Lee. Timed pulsatile drug delivery systems, U.S.
Patent US 7048945 B2, 2006.
73. J. G. Devane, P. Stark, N. M. M. Fanning and G. S.
Rekhi. Multiparticulate modified release
composition, U.S. Patent US 6902742 B2, 2005.
74. R. Ting and C. Hsiao. Press Coated, Pulsatile drug
delivery system suitable for oral administration,
U.S. Patent US 6730321 B2, 2004.
75. K. Sharma, J. Hussain and H. F. Khorakiwala.
Composition for Pulsatile delivery of Diltiazem and
process of manufacture, U.S. Patent US 6635277 B2,
2003.